The company's flagship product, Feraheme, is used as an IV iron replacement therapy for adult patients with chronic kidney disease suffering from anemia. AMAG Pharmaceuticals also offers GastroMARK, an imaging aid used with magnetic resonance imaging. The company invests in clinical research to expand the body of knowledge in therapeutic areas and works with doctors, specialists, and patient advocates to improve patient care.